INSIGHTS ON DRUG DEVELOPMENT
-
Digital Transformation Essentials: AI Readiness, What Do You Need To Know?
Unlock the full potential of AI and digital solutions with these practical steps to begin moving your BioPharma organization's goals forward with optimized data usage.
-
Formulation Strategies For Enabling "Undevelopable" Compounds
KinetiSol enhances bioavailability of poorly soluble drugs like Vemurafenib by producing dense amorphous dispersions, outperforming traditional MBP methods in pharmacokinetics and dissolution.
-
Is Lipinski's Rule Of Five Still Relevant In Drug Development?
Some drugs violate multiple Ro5 elements but remain developable, while some molecules adhere strictly to the Ro5, but their properties are not conducive to development.
-
Modeling Virus Evolution, Rapid Drug Repurposing With Human Airway Lung-Chips
In this presentation, we introduce the human Airway Lung-Chip, which can model influenza virus infection and evolution in vitro and evaluate therapeutics for both influenza and SARS-CoV-2.
-
Softgel Formulation: Addressing Stability, Shelf-Life, And Bioavailability5/16/2024
A CDMO that has expertise and resources in softgel formulation can help companies address stability issues, improve drug bioavailability, or ensure compliance with regulations.
-
Scale-Up Of A Transient rAAV Production Process11/3/2025
Scalable rAAV production is achievable with a transient cell line and optimized bioreactor setup, delivering high titers and reduced impurities, now validated at 200 L scale for commercial readiness.
-
Why Biopharma Breakthroughs Aren't Moving The Market10/20/2025
Biopharma is innovating fast but falling short commercially. Reveal key ecosystem gaps and five strategic actions to help strengthen resilience, accelerate performance, and futureproof organizations.
-
Formulation Development Of Enterically Protected Spray Dried Dispersions11/17/2025
Adrulipase spray-dried dispersions were evaluated to create an orally delivered, enteric-protected enzyme. The lead formulation provided the best acid protection, rapid release, and stability.
-
How To Get Started With Organ-On-A-Chip Technology4/18/2024
Explore the advantages of Organ-on-a-Chip technology over 2D cell culture as well as data-driven examples demonstrating the enhanced physiological relevance of Organ-Chips.
DRUG DEVELOPMENT SOLUTIONS
-
Discover a service that offers access to certified engineers for training on system use and maintenance to ensure quality results, reliability, and productivity while reducing costs and extending equipment lifespan.
-
Our combined method development experience ensures that client methods are robust, effective, flexible, innovative and allow true stability indication.
-
Rapid, high-throughput IgG quantification assay. Available in 96 & 384-well microplate options.
-
SimpleStep ELISA® kits are sandwich ELISA assays that we have developed to be as simple and effective as possible. Unlike traditional sandwich ELISAs, which take more than three hours to run, SimpleStep ELISA kits generate data in just 90 minutes without compromising performance, using only one wash step and recombinant antibodies for exceptional specificity.
-
This intuitive and reliable HPLC system supports First Time Quality (FTQ) by reducing the risk of common errors and improving the accuracy of analytical measurements.